4DMedical (ASX:4DX) expanded its partnership with the University of Chicago Medicine to include commercial deployment of CT:VQ cardiothoracic imaging product, according to a Friday Australian bourse filing.
The University of Chicago Medicine will become the fifth US academic medical center to adopt the CT:VQ product, per the filing.
The expanded arrangement includes a renewed imaging analysis platform agreement and a commercial contract, including an initial package of prepaid CT:VQ scans to boost clinical deployment.
4DMedical's shares jumped past 7% in recent Friday trade.